Feed Insights Top Reports Pricing

⌘K

07:53:56·140d

ANALYSTRatingvia Quantisnow

Fiserv downgraded by Northcoast

ByQuantisnow·Wall Street's wire, on your screen.

FISV· Fiserv Inc.

Real Estate

Plus alert sent

Quantisnow Plus members were alerted at 07:53:58 ET - 1.9s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment FISV files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FISV (Fiserv Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Chief Financial Officer Todd Paul M bought $499,982 worth of shares (10,060 units at $49.70), increasing direct ownership by 6% to 184,107 units (SEC Form 4)
SEC Form 8-K filed by Fiserv Inc.
SEC Form 424B5 filed by Fiserv Inc.
Director Mamilli Wafaa bought $149,746 worth of shares (2,960 units at $50.59), increasing direct ownership by 24% to 15,386 units (SEC Form 4)
Chief Admin. and Legal Officer Rosman Adam L. bought $500,700 worth of shares (10,150 units at $49.33), increasing direct ownership by 8% to 136,724 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022